You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 124 No. 8, August 1988 TABLE OF CONTENTS
  Archives
  •  Online Features
  EDITORIAL REVIEW
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Sinus Histiocytosis With Massive Lymphadenopathy

Current Status and Future Directions

Elliott Foucar, MD; Juan Rosai, MD; Ronald F. Dorfman, MD, FRCPath

Arch Dermatol. 1988;124(8):1211-1214.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In the present issue of the ARCHIVES, Suster et al1 describe a 72-year-old woman with large soft-tissue masses that spontaneously disappeared over a period of several weeks. In spite of the absence of lymphadenopathy, the authors cautiously suggest the diagnosis sinus histiocytosis with massive lymphadenopathy (SHML) (Rosai-Dorfman disease), based primarily on the biopsy finding of a certain cytologic subtype of S100-positive histiocytes exhibiting lymphocytophagocytosis. It is appropriate to ask just how reliable these morphological and immunologic features are in segregating a specific disease entity. If the findings are reliable, what is our current understanding of the clinical and pathologic features of this disease, how is it related to other "histiocytoses," and what are the major directions for investigation of this disease?

Histopathologic observations are currently used to subclassify many disease processes that are associated with proliferation of lymphoid and histiocytic cell lines, although immunophenotypic and immunogenotypic studies . . . [Full Text PDF of this Article]


Author Affiliations

From the Department of Pathology, Presbyterian Hospital, and the Departments of Pathology and Dermatology, University of New Mexico School of Medicine, Albuquerque (Dr Foucar), the Department of Pathology, Yale University School of Medicine, New Haven, Conn (Dr Rosai), and the Department of Pathology, Stanford (Calif) University Medical School (Dr Dorfman).


Footnotes

Accepted for publication May 3, 1988.

Reprint requests to Department of Pathology, Yale University School of Medicine, 310 Cedar St, PO Box 3333, New Haven, CT 06510-8070 (Dr Rosai).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1988 American Medical Association. All Rights Reserved.